Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (270) 270
Patent (20) 20
Publication (11) 11
Book / eBook (3) 3
Book Chapter (1) 1
Conference Proceeding (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (118) 118
female (86) 86
male (80) 80
middle aged (61) 61
index medicus (58) 58
aged (49) 49
adult (48) 48
risk factors (25) 25
animals (24) 24
hypertension (22) 22
atherosclerosis (21) 21
medicine, research & experimental (20) 20
mortality (20) 20
peripheral vascular disease (20) 20
disease (19) 19
cardiovascular diseases (17) 17
medicine, general & internal (17) 17
prospective studies (17) 17
risk (16) 16
blood pressure (15) 15
epidemiology (15) 15
endothelial dysfunction (14) 14
health aspects (14) 14
medicine (14) 14
poland (14) 14
treatment outcome (14) 14
abridged index medicus (13) 13
adma (13) 13
analysis (13) 13
cardiovascular disease (13) 13
lymphedema (13) 13
prevalence (13) 13
public, environmental & occupational health (13) 13
aged, 80 and over (12) 12
arginine - analogs & derivatives (12) 12
health risk assessment (12) 12
physiology (12) 12
surveys and questionnaires (12) 12
rats (11) 11
arginine - blood (10) 10
human necessities (10) 10
hygiene (10) 10
medical or veterinary science (10) 10
metaanalysis (10) 10
nitric-oxide synthase (10) 10
oxidative stress (10) 10
preparations for medical, dental, or toilet purposes (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
studies (10) 10
asymmetric dimethylarginine (9) 9
immunology (9) 9
inflammation (9) 9
lymphedema - etiology (9) 9
nitric oxide (9) 9
obesity (9) 9
patients (9) 9
prevention (9) 9
blood-pressure (8) 8
cancer (8) 8
cohort studies (8) 8
cross-sectional studies (8) 8
diabetes (8) 8
environmental sciences (8) 8
foods or foodstuffs (8) 8
management (8) 8
oncology (8) 8
poland - epidemiology (8) 8
surgery (8) 8
their treatment, not covered by other classes (8) 8
age factors (7) 7
arginine - metabolism (7) 7
cardiovascular diseases - epidemiology (7) 7
cardiovascular-disease (7) 7
care and treatment (7) 7
case-control studies (7) 7
coronary-heart-disease (7) 7
exercise (7) 7
expression (7) 7
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (7) 7
health (7) 7
lymphangiogenesis (7) 7
lymphatic system (7) 7
middle (7) 7
nitric oxide - metabolism (7) 7
population (7) 7
preservation of foods or foodstuffs, in general (7) 7
prognosis (7) 7
rehabilitation (7) 7
research (7) 7
risk assessment (7) 7
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (7) 7
walking (7) 7
young adult (7) 7
adolescent (6) 6
adults (6) 6
biochemistry & molecular biology (6) 6
biotechnology & applied microbiology (6) 6
breast neoplasms - complications (6) 6
breast-cancer (6) 6
cardiac & cardiovascular systems (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Epitopes identified in GAPDH from Clostridium difficile recognized as common antigens with potential autoimmunizing properties
by Razim, Agnieszka and Pacyga, Katarzyna and Aptekorz, Małgorzata and Martirosian, Gayane and Szuba, Andrzej and Pawlak-Adamska, Edyta and Brzychczy-Włoch, Monika and Myc, Andrzej and Gamian, Andrzej and Górska, Sabina
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 13946 - 12
Clostridium difficile (CD) infections are a growing threat due to the strain resistance to antibiotic treatment and the emergence of hypervirulent strains. One... 
STREPTOCOCCUS-PNEUMONIAE | PROTEIN | MULTIPLE-SCLEROSIS | PROTECTION | HEPATITIS-B VACCINATION | GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE | MULTIDISCIPLINARY SCIENCES | DISEASE | CELL-SURFACE | ANTIBODY | CANDIDATE VACCINE | Proteins | Antigens | Cross-reactivity | Glyceraldehyde-3-phosphate dehydrogenase | Vaccines | Epitopes | Patients | Strains (organisms) | Immune response (humoral) | Colonization
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Wejście zapasowe
: wiersze
by Szuba, Andrzej, 1949
1980, Wyd. 1. --, ISBN 8321600794, 58
Book
Details down arrow
3. Full Text Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
by Mente, Andrew, Prof and O'Donnell, Martin, Prof and Rangarajan, Sumathy, MSc and Dagenais, Gilles, MD and Lear, Scott, PhD and McQueen, Matthew, Prof and Diaz, Rafael, Prof and Avezum, Alvaro, Prof and Lopez-Jaramillo, Patricio, Prof and Lanas, Fernando, Prof and Li, Wei, Prof and Lu, Yin, PhD and Yi, Sun, MPH and Rensheng, Lei, MB and Iqbal, Romaina, PhD and Mony, Prem, Prof and Yusuf, Rita, Prof and Yusoff, Khalid, Prof and Szuba, Andrzej, Prof and Oguz, Aytekin, Prof and Rosengren, Annika, Prof and Bahonar, Ahmad, MD and Yusufali, Afzalhussein, Prof and Schutte, Aletta Elisabeth, PhD and Chifamba, Jephat, DPhil and Mann, Johannes F E, Prof and Anand, Sonia S, Prof and Teo, Koon, Prof and Yusuf, S, Prof and PURE Investigator and TARGET TRANSCEND Investigator and EPIDREAM Investigator and PURE, EPIDREAM and ONTARGET/TRANSCEND Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 465 - 475
Summary Background Several studies reported a U-shaped association between urinary sodium excretion and cardiovascular disease events and mortality. Whether... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | LOW-INCOME COUNTRIES | HIGH-RISK | PLASMA-RENIN ACTIVITY | HEART-FAILURE | DISEASE | SALT INTAKE | SPOT URINE | POTASSIUM EXCRETION | BLOOD-PRESSURE | Blood Pressure | Cardiovascular Diseases - etiology | Prospective Studies | Global Health | Risk Assessment | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Male | Hypertension - physiopathology | Sodium - urine | Diet, Sodium-Restricted | Aged, 80 and over | Hypertension - complications | Adult | Female | Sodium, Dietary - administration & dosage | Aged | Hypertension - diet therapy | Hypertension - urine | Hypertension | Canada | Analysis | Mortality | China | Cardiology | Epidemiology | Studies | Urine | Sodium | Cardiovascular disease | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
by Connolly, Stuart J and Eikelboom, John W and Bosch, Jackie and Dagenais, Gilles and Dyal, Leanne and Lanas, Fernando and Metsarinne, Kaj and O'Donnell, Martin and Dans, Anthony L and Ha, Jong-Won and Parkhomenko, Alexandr N and Avezum, Alvaro A and Lonn, Eva and Lisheng, Liu and Torp-Pedersen, Christian and Widimsky, Petr and Maggioni, Aldo P and Felix, Camilo and Keltai, Katalin and Hori, Masatsugu and Yusoff, Khalid and Guzik, Tomasz J and Bhatt, Deepak L and Branch, Kelley R H and Cook Bruns, Nancy and Berkowitz, Scott D and Anand, Sonia S and Varigos, John D and Fox, Keith A A and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and RECH, RAFAEL and ... and COMPASS Investigators and COMPASS investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 205 - 218
Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence of acute thrombotic events involving activation of... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | ORAL RIVAROXABAN | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Coronary Artery Disease - drug therapy | Morbidity | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Aged | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Anticoagulants | Aspirin | Stroke | Heart attacks | Mortality | Coronary artery | Clinical trials | Cardiovascular disease | Coronary artery disease | Disease control | Disease prevention | Coronary vessels | Acute coronary syndromes | Thromboembolism | Health risk assessment | Drug therapy | Heart diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Letter to the editor: Lymphangioleiomyomatosis (LAM) - Questions
by Szuba, Andrzej
Lymphology, ISSN 0024-7766, 03/2015, Volume 48, Issue 1, pp. 51 - 52
Sirolimus (Rapamycin) | Lymphangioleiomyomatosis (LAM) | Angiorayolipoma (AML) | Tuberous sclerosis LAM | Sporadic LAM | Vascular endothelial growth factors (VEGF)
Journal Article
Details down arrow
7. Full Text Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
by Khatib, Rasha, PhD and McKee, Martin, Prof and Shannon, Harry, Prof and Chow, Clara, PhD and Rangarajan, Sumathy, MSc and Teo, Koon, Prof and Wei, Li, Prof and Mony, Prem, MD and Mohan, Viswanathan, MD and Gupta, Rajeev, PhD and Kumar, Rajesh, MD and Vijayakumar, Krishnapillai, Prof and Lear, Scott A, Prof and Diaz, Rafael, MD and Avezum, Alvaro, PhD and Lopez-Jaramillo, Patricio, Prof and Lanas, Fernando, MD and Yusoff, Khalid, Prof and Ismail, Noorhassim, MD and Kazmi, Khawar, MBBS and Rahman, Omar, Prof and Rosengren, Annika, Prof and Monsef, Nahed, MD and Kelishadi, Roya, Prof and Kruger, Annamarie, Prof and Puoane, Thandi, Prof and Szuba, Andrzej, Prof and Chifamba, Jephat, PhD and Temizhan, Ahmet, MD and Dagenais, Gilles, Prof and Gafni, Amiram, Prof and Yusuf, Salim, Prof and PURE study investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10013, pp. 61 - 69
Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible... 
Internal Medicine | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies—A prospective study
by Chachaj, Angelika and Wiśniewski, Jerzy and Rybka, Justyna and Butrym, Aleksandra and Biedroń, Monika and Krzystek-Korpacka, Małgorzata and Fleszar, Mariusz Grzegorz and Karczewski, Maciej and Wróbel, Tomasz and Mazur, Grzegorz and Gamian, Andrzej and Szuba, Andrzej
PLoS ONE, ISSN 1932-6203, 05/2018, Volume 13, Issue 5, p. e0197148
The study was designed to determine the associations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginines plasma concentrations with all-cause mortality... 
DIMETHYLAMINOHYDROLASE DDAH | PLASMA | CARDIOVASCULAR RISK-FACTOR | ENDOTHELIAL DYSFUNCTION | ACCURATE QUANTIFICATION | RAT-KIDNEY | NITRIC-OXIDE SYNTHASE | MULTIDISCIPLINARY SCIENCES | L-ARGININE PARADOX | ADMA | STAGE RENAL-DISEASE | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Survival Rate | Leukemia, Myeloid, Acute - blood | Arginine - analogs & derivatives | Case-Control Studies | Biomarkers, Tumor - blood | Leukemia, Myeloid, Acute - mortality | Young Adult | Leukemia, Myeloid, Acute - diagnosis | Lymphoma, Non-Hodgkin - blood | Arginine - blood | Aged, 80 and over | Adult | Female | Leukemia, Lymphocytic, Chronic, B-Cell - blood | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Lymphoma, Non-Hodgkin - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Lymphoma, Non-Hodgkin - diagnosis | Cancer patients | Chemical properties | Cardiovascular diseases | Health aspects | Nitric oxide | Risk factors | Oxidative stress |